Researchers have long linked vitamin D status to depressive symptoms in older adults. Now a new generation of high-bioavailability supplements is bringing the conversation into Indian living rooms.
Vitamin D deficiency affects an estimated 70–90% of Indian adults over 50, and researchers are now exploring its links to mood and emotional wellbeing.
For decades, vitamin D has been associated almost exclusively with bone health. But a growing body of peer-reviewed research is now examining its role in another area entirely: mood regulation in older adults. The findings, combined with the well-documented vitamin D deficiency crisis in India, are pushing the conversation in a new direction.
What experts are saying
A four-year cohort study published in the Journal of the American Medical Directors Association found that community-dwelling older adults with vitamin D deficiency had a 75% higher likelihood of developing depression compared to those with adequate levels.
Source: Briggs R, et al. (2019). Vitamin D deficiency is associated with an increased likelihood of incident depression in community-dwelling older adults. JAMDA, 20(5):517–523.
A 2022 review in Current Nutrition Reports describes the active form of vitamin D, calcitriol, as a "neurosteroid" that influences the synthesis of serotonin, dopamine, and noradrenaline. The review notes that vitamin D receptors are present in the hippocampus, the brain region central to emotional processing.
Source: Akpınar Ş, Karadağ MG. (2022). Is Vitamin D Important in Anxiety or Depression? Curr Nutr Rep, 11(4):675–681.
A randomized controlled trial published in BMC Women's Health found that participants receiving 90 μg/day of vitamin K2 (MK-7) for eight weeks showed a statistically significant reduction in depressive symptoms compared to those receiving placebo.
Source: Tarkesh F, et al. (2022). Effect of vitamin K2 administration on depression status. BMC Women's Health, 22:315.
"Individuals with higher vitamin D levels have a lower likelihood of developing depressive symptoms across multiple cross-sectional and cohort studies." — Akpınar & Karadağ, Current Nutrition Reports, 2022
Why this matters now in India
Vitamin D deficiency in India is not a marginal concern. Studies estimate that 70 to 90 per cent of Indian adults over 50 have insufficient vitamin D levels, driven by a combination of indoor lifestyles, dietary patterns low in fortified foods, sunscreen use, and reduced skin synthesis with age.
The same population is also navigating one of the most underdiagnosed mental health categories in the country: late-life depression. The World Health Organisation estimates that 5.7% of people aged 60 and above globally meet the criteria for a depressive disorder, and Indian community studies suggest the figure may be considerably higher when sub-clinical mood symptoms are included.
The convergence of these two trends — widespread vitamin D deficiency and rising recognition of mood disorders in older Indians — is what has researchers and nutritionists paying closer attention.

How it works
Vitamin D is unusual among nutrients in that it functions as both a vitamin and a hormone. Once converted to its active form, it crosses the blood-brain barrier and binds to vitamin D receptors expressed in the hippocampus and other limbic regions. There, it appears to support the activity of tyrosine hydroxylase, the rate-limiting enzyme in the production of dopamine and noradrenaline. It also helps regulate the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress-response system.
Vitamin K2, particularly the long-chain MK-7 form, plays a complementary role. While best known for directing calcium to bone (rather than arteries), emerging research suggests K2 also supports neurobiological pathways relevant to mood through anti-inflammatory and antioxidative mechanisms, and through vitamin K-dependent proteins like GAS6 and osteocalcin that play a role in neuronal health.
The challenge with both nutrients in older adults: absorption. Vitamin D is highly hydrophobic, and gut absorption declines meaningfully with age. This is why a new generation of formulations is using liposomal delivery to address the bioavailability gap.
"Vitamin D promotes serotonin synthesis and protects serotonergic neurons. Deficiency has been linked to impaired serotonin production." — From a 2022 review of vitamin D and mood research, Current Nutrition Reports
What to know
Form matters. Vitamin D3 (cholecalciferol) is the form the body produces from sunlight and the form best supported in human trials. Vitamin K2 as MK-7 has a 72-hour half-life, significantly longer than other K forms, allowing it to reach tissues outside the liver.
Bioavailability is the bottleneck. Conventional D3 supplements often deliver poor absorption in older adults due to age-related declines in gut function. Phospholipids-based liposomal delivery, which encapsulates the nutrient in a phospholipid bilayer, has been shown in published research to substantially improve bioavailability.
The pairing is intentional. D3 and K2 are commonly co-formulated because K2 helps direct the calcium that D3 mobilises toward bone rather than soft tissue.
The emerging mood evidence is associational, not curative. No supplement should replace clinical care for diagnosed depression. The current research describes a relationship between vitamin status and mood, and points to the importance of correcting deficiency, particularly in older adults.

Where to find it
A small but growing number of Indian supplement brands are now offering liposomal D3+K2 formulations targeted at adults over 50. Among them, Meru Activs has launched a Phospholipid Vitamin D3 + K2 product that uses a proprietary liposomal technology (LECIVA-D3Lip + K27) developed by their formulation partner, VAV Life Sciences. The product is positioned for the 50+ Indian adult, is allergen-free, gluten-free, and lactose-free, and is sold as a 30-day strip.
The brand notes that mood regulation is presented as a secondary benefit alongside the primary bone, joint, and immunity claims, and that the formulation is intended to support — not replace — medical care.